Sex differences in cardiovascular outcome during progression of aortic valve stenosis

Dana Cramariuc, Barbara Patricia Rogge, Mai Tone Lønnebakken, Kurt Boman, Edda Bahlmann, Christa Gohlke-Bärwolf, John B Chambers, Terje R Pedersen, Eva Gerdts, Dana Cramariuc, Barbara Patricia Rogge, Mai Tone Lønnebakken, Kurt Boman, Edda Bahlmann, Christa Gohlke-Bärwolf, John B Chambers, Terje R Pedersen, Eva Gerdts

Abstract

Objective: Women with severe aortic valve stenosis (AS) have better LV systolic function and more concentric LV geometry than their male counterparts. However, sex differences in cardiovascular (CV) outcome during progression of AS have not been reported from a longitudinal prospective study.

Methods: Doppler echocardiography and CV events were recorded during a median of 4.0 years in 979 men and 632 women aged 28-86 (mean 67±10) years in the Simvastatin Ezetimibe in Aortic Stenosis (SEAS) study. LV systolic function was assessed by EF and midwall shortening (MWS). Study outcomes were AS-related events, ischaemic CV events and total mortality.

Results: The annular cumulative incidence of AS events, ischaemic CV events and death was 8.1%, 3.4% and 2.8% in women, and 8.9%, 4.4% and 2.4% in men, respectively. Women and men had similar AS progression rate whether measured by peak jet velocity, mean gradient or valve area. In multivariate analyses, female sex independently predicted less reduction in LV MWS and EF during follow-up (both p<0.05). In time-varying Cox analyses, women had a 40% lower rate of ischaemic CV events (95% CI 21% to 54%), in particular, more than 50% lower rate of stroke and coronary artery bypass grafting, and a 31% lower all-cause mortality (95% CI 1% to 51%), independent of active study treatment, age and hypertension, as well as time-varying valve area, low systolic function and abnormal LV geometry. AS event rate did not differ by sex.

Conclusions: In the SEAS study, women and men had similar rates of AS progression and AS-related events. However, women had lower total mortality and ischaemic CV event rate than men independent of confounders.

Trial registration number: ClinicalTrials.gov identifier: NCT00092677.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Figures

Figure 1
Figure 1
Progression of aortic valve stenosis in women and men assessed by 4 key variables: peak aortic jet velocity, mean pressure gradient, aortic valve area and energy loss index (ELI), at 4 different study visits: baseline, 1-year visit, 2-year visit and final visit. *p

Figure 2

Prevalence of low midwall shortening…

Figure 2

Prevalence of low midwall shortening (MWS) (continuous line) and low EF (stippled line)…

Figure 2
Prevalence of low midwall shortening (MWS) (continuous line) and low EF (stippled line) in women and men at different study visits. Mean values are adjusted for repeated measurements over time using full-factorial analysis of variance. p Value of significance for comparison between women and men at each visit.

Figure 3

Survival free of ischaemic cardiovascular…

Figure 3

Survival free of ischaemic cardiovascular (CV) events in women and men during progression…

Figure 3
Survival free of ischaemic cardiovascular (CV) events in women and men during progression of aortic valve stenosis with adjustment for covariates (the means of age, hypertension, active study treatment, energy loss index, low EF and midwall shortening, and abnormal LV geometry) and p value of significance based on Cox proportional hazard analyses.

Figure 4

Overall survival in women and…

Figure 4

Overall survival in women and men during progression of aortic valve stenosis with…

Figure 4
Overall survival in women and men during progression of aortic valve stenosis with adjustment for covariates (the means of age, hypertension, active study treatment, energy loss index, low EF and midwall shortening, and abnormal LV geometry) and p value of significance based on Cox proportional hazard analysis.
Figure 2
Figure 2
Prevalence of low midwall shortening (MWS) (continuous line) and low EF (stippled line) in women and men at different study visits. Mean values are adjusted for repeated measurements over time using full-factorial analysis of variance. p Value of significance for comparison between women and men at each visit.
Figure 3
Figure 3
Survival free of ischaemic cardiovascular (CV) events in women and men during progression of aortic valve stenosis with adjustment for covariates (the means of age, hypertension, active study treatment, energy loss index, low EF and midwall shortening, and abnormal LV geometry) and p value of significance based on Cox proportional hazard analyses.
Figure 4
Figure 4
Overall survival in women and men during progression of aortic valve stenosis with adjustment for covariates (the means of age, hypertension, active study treatment, energy loss index, low EF and midwall shortening, and abnormal LV geometry) and p value of significance based on Cox proportional hazard analysis.

References

    1. Iung B, Baron G, Butchart EG, et al. . A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24:1231–43.
    1. Nkomo VT, Gardin JM, Skelton TN, et al. . Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005–11.
    1. Otto CM. Valvular aortic stenosis: disease severity and timing of intervention. J Am Coll Cardiol 2006;47:2141–51.
    1. Baumgartner H, Hung J, Bermejo J, et al. . Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009;22:1–23.
    1. Aurigemma GP, Silver KH, McLaughlin M, et al. . Impact of chamber geometry and gender on left ventricular systolic function in patients >60 years of age with aortic stenosis. Am J Cardiol 1994;74:794–8.
    1. Carroll JD, Carroll EP, Feldman T, et al. . Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation 1992;86:1099–107.
    1. Douglas PS, Otto CM, Mickel MC, et al. . Gender differences in left ventricle geometry and function in patients undergoing balloon dilatation of the aortic valve for isolated aortic stenosis. NHLBI Balloon Valvuloplasty Registry. Br Heart J 1995;73:548–54.
    1. Cramariuc D, Gerdts E, Davidsen ES, et al. . Myocardial deformation in aortic valve stenosis: relation to left ventricular geometry. Heart 2010;96:106–12.
    1. Aggarwal SR, Clavel MA, Messika-Zeitoun D, et al. . Sex differences in aortic valve calcification measured by multidetector computed tomography in aortic stenosis. Circ Cardiovasc Imaging 2013;6:40–7.
    1. Cramariuc D, Rieck AE, Staal EM, et al. . Factors influencing left ventricular structure and stress-corrected systolic function in men and women with asymptomatic aortic valve stenosis (a SEAS Substudy). Am J Cardiol 2008;101:510–15.
    1. Lang RM, Bierig M, Devereux RB, et al. . Recommendations for chamber quantification. Eur J Echocardiogr 2006;7:79–108.
    1. Rieck AE, Cramariuc D, Staal EM, et al. . Impact of hypertension on left ventricular structure in patients with asymptomatic aortic valve stenosis (a SEAS substudy). J Hypertens 2010;28:377–83.
    1. Shames S, Gillam LD. Sex differences in aortic valve calcification. Circ Cardiovasc Imaging 2013;6:8–10.
    1. Rossebo AB, Pedersen TR, Boman K, et al. . Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008;359:1343–56.
    1. Bahlmann E, Gerdts E, Cramariuc D, et al. . Prognostic value of energy loss index in asymptomatic aortic stenosis. Circulation 2013;127:1149–56.
    1. de Simone G, Izzo R, Chinali M, et al. . Does information on systolic and diastolic function improve prediction of a cardiovascular event by left ventricular hypertrophy in arterial hypertension? Hypertension 2010;56:99–104.
    1. Bella JN, Palmieri V, Roman MJ, et al. . Gender differences in left ventricular systolic function in American Indians (from the Strong Heart Study). Am J Cardiol 2006;98:834–7.
    1. Gerdts E, Stangeland L, Engedal H, et al. . Postoperative Doppler echocardiographic evaluation in different sizes of Medtronic-Hall, Biocor and Carpentier-Edwards S.A.V. prosthetic aortic valves. Scand J Thorac Cardiovasc Surg 1994;28:25–9.
    1. Petrov G, Regitz-Zagrosek V, Lehmkuhl E, et al. . Regression of myocardial hypertrophy after aortic valve replacement: faster in women? Circulation 2010;122(11 Suppl):S23–8.
    1. Villari B, Campbell SE, Schneider J, et al. . Sex-dependent differences in left ventricular function and structure in chronic pressure overload. Eur Heart J 1995;16:1410–19.
    1. Novaro GM, Katz R, Aviles RJ, et al. . Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study. J Am Coll Cardiol 2007;50:1992–8.
    1. Rosenhek R, Klaar U, Schemper M, et al. . Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. Eur Heart J 2004;25:199–205.
    1. Mannsverk J, Wilsgaard T, Njolstad I, et al. . Age and gender differences in incidence and case fatality trends for myocardial infarction: a 30-year follow-up. The Tromso Study. Eur J Prev Cardiol 2012;19:927–34.
    1. Pibarot P, Dumesnil JG. Assessment of aortic stenosis severity: check the valve but don't forget the arteries! Heart 2007;93:780–2.
    1. Roger VL, Go AS, Lloyd-Jones DM, et al. . Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation 2012;125:e2–220.
    1. Williams M, Kodali SK, Hahn RT, et al. . Sex-related differences in outcomes following transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights From The PARTNER Trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol 2014;63:1522–8.
    1. Nishimura RA, Otto CM, Bonow RO, et al. . 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63:2438–88.
    1. Rieck AE, Cramariuc D, Boman K, et al. . Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events. Hypertension 2012;60:90–7.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner